Skip to main content
Loading

Innovation to Impact: Advancing New Therapeutic Modalities from Lab to Clinic

26 Sep 2025
 Innovation in Therapeutic Modalities
  • How Junevity is leveraging novel biomaterials, nanocarriers, and tissue-specific strategies to improve therapeutic precision
  • Integrating AI and Multi-Omics in Modality Design: Harnessing computational biology and systems-level data to create smarter, more adaptive treatment modalities
  • Bridging Translational Gaps: Strategies for accelerating preclinical-to-clinic transitions of novel modalities while maintaining scalability and regulatory compliance
Industry Expert
Janine Sengstack, Co-Founder & Chief Scientific Officer - Junevity